Invalidation of a Commercially Available Human 5α-Dihydrotestosterone Immunoassay
September 2013
in “
Steroids
”
TLDR The DHT immunoassay is unreliable due to high cross-reactivity with testosterone.
The study invalidated a commercially available dihydrotestosterone (DHT) immunoassay due to significant cross-reactivity with testosterone, which ranged from 18% to 99%. This cross-reactivity led to DHT concentrations being overestimated by 79% to over 1000% compared to the gold-standard LC–MS/MS method. The immunoassay failed to detect reductions in DHT following finasteride treatment, unlike LC–MS/MS. The study involved older hypogonadal men in a 12-month trial, highlighting that the immunoassay's results were not reliable for assessing DHT in biological fluids containing testosterone.